Veracyte Financial Ratios
NASDAQ: VCYTHealth CareMedical SpecialitiesUSD
45.23+1.63 (+3.74%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Veracyte ratio analysis
Veracyte earned a net margin of 12.8% in FY 2025, up from 5.4% a year earlier. Gross margin was 70.1% compared with a median of 63.6% over the prior 7 years. Return on equity reached 5.1%, meaning Veracyte generated 0.05 dollars of profit for every dollar of shareholders' equity.
Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Veracyte financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 51.70 | 135.19 | — | — | — | — | — | — | — | — |
| Price / sales | 6.44 | 7.19 | 5.54 | 5.73 | 12.74 | 22.18 | 10.17 | 5.73 | 3.08 | 3.43 |
| Price / book | 2.54 | 2.73 | 1.91 | 1.58 | 2.55 | 6.19 | 5.11 | 6.61 | 5.95 | 3.75 |
| Gross margin | 70.1% | 66.9% | 63.6% | 59.2% | — | — | 70.0% | 64.0% | 60.8% | 60.9% |
| Operating margin | 11.2% | 3.6% | -23.8% | -13.9% | -37.3% | -30.1% | -12.6% | -24.2% | -36.9% | -44.3% |
| Net margin | 12.8% | 5.4% | -20.6% | -12.3% | -34.4% | -29.7% | -10.5% | -25.0% | -43.1% | -48.2% |
| Free cash flow margin | 24.5% | 14.3% | 9.5% | -0.3% | -16.9% | -10.7% | -5.0% | -16.7% | -35.7% | -49.5% |
| Return on equity (ROE) | 5.1% | 2.1% | -7.1% | -3.4% | -6.9% | -8.3% | -5.3% | -28.8% | -83.3% | -52.6% |
| Return on assets (ROA) | 4.7% | 1.9% | -6.7% | -3.2% | -6.4% | -7.6% | -4.6% | -19.1% | -39.4% | -31.0% |
| Debt / equity | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.32 | 0.67 | 0.42 |
| Current ratio | 8.15 | 4.73 | 4.66 | 3.97 | 3.79 | 22.39 | 10.74 | 7.42 | 4.48 | 6.38 |
| Revenue growth | 16.0% | 23.5% | 21.8% | 35.1% | 86.8% | -2.4% | 30.8% | 27.9% | 10.6% | 31.5% |
| EPS growth | 164.5% | — | — | — | — | — | — | — | — | — |